Phenotype, Genotype and Biomarkers 2
Study Purpose:
The purpose of this study is to learn more about amyotrophic lateral sclerosis (ALS) and other related neurodegenerative diseases, including frontotemporal dementia (FTD), primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA) and multisystem proteinopathy (MSP). More precisely, the investigator wants to identify the links that exist between the disease phenotype (phenotype refers to observable signs and symptoms) and the disease genotype (genotype refers to your genetic information). The investigator also wants to identify biomarkers of ALS and related diseases.
Disease:
Amyotrophic Lateral Sclerosis (ALS), Familial ALS, Sporadic ALS, Primary Lateral Sclerosis (PLS), Hereditary Spastic Paraplegia (HSP), Healthy Volunteer, Healthy Volunteer with a Family History of ALSStudy Type:
Observational StudyStudy Category:
Biomarkers/ImagingStudy Status:
EnrollingPhase:
Not ApplicableStudy Chair(s)/Principal Investigator(s):
Michael Benatar, MD, PhD University of Miami
Clinicaltrials.gov ID (11 digit #):
NCT04875416Neals Affiliated?
NoCoordinating Center Contact Information
University of MiamiMichael Benatar, MD, PhD / .(JavaScript must be enabled to view this email address) / 844-837-1031
.(JavaScript must be enabled to view this email address) Miami, Florida 33136 United States